Stay updated on FANCOSTEM-1 Clinical Trial: FANCA Gene Lentiviral Transduction
Sign up to get notified when there's something new on the FANCOSTEM-1 Clinical Trial: FANCA Gene Lentiviral Transduction page.

Latest updates to the FANCOSTEM-1 Clinical Trial: FANCA Gene Lentiviral Transduction page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record provides details of the completed Phase 2 Fanconi anemia study, including its plerixafor and filgrastim regimen, participant criteria, study locations, and safety and cell-collection outcomes.SummaryDifference42%

- Check19 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces NIH updates and FAQs about using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a transition.SummaryDifference1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error page, with the footer revision changing from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page shows a 403 Forbidden screen with an access-denied message, replacing the study details and navigation.SummaryDifference17%

Stay in the know with updates to FANCOSTEM-1 Clinical Trial: FANCA Gene Lentiviral Transduction
Enter your email address, and we'll notify you when there's something new on the FANCOSTEM-1 Clinical Trial: FANCA Gene Lentiviral Transduction page.